Neutrophil calprotectin identifies severe pulmonary disease in COVID‐19

Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus–Infected Pneumonia in Wuhan, China

(2020) Dawei Wang et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Targeting potential drivers of COVID-19: Neutrophil extracellular traps

(2020) Betsy J. Barnes et al.   JOURNAL OF EXPERIMENTAL MEDICINE

Neutrophil-to-lymphocyte ratio as an independent risk factor for mortality in hospitalized patients with COVID-19

(2020) Yuwei Liu et al.   JOURNAL OF INFECTION

Prevalence of venous thromboembolism in patients with severe novel coronavirus pneumonia

(2020) Songping Cui et al.   JOURNAL OF THROMBOSIS AND HAEMOSTASIS

Neutrophil Extracellular Traps (NETs) Contribute to Immunothrombosis in COVID-19 Acute Respiratory Distress Syndrome

(2020) Elizabeth A Middleton et al.   BLOOD

Incidence of thrombotic complications in critically ill ICU patients with COVID-19

(2020) F.A. Klok et al.   THROMBOSIS RESEARCH

Neutrophil extracellular traps in COVID-19

(2020) Yu Zuo et al.   JCI Insight

New (re)purpose for an old drug: purinergic modulation may extinguish the COVID-19 thromboinflammatory firestorm

(2020) Yogendra Kanthi et al.   JCI Insight

Neutrophil Extracellular Traps

(2019) Charlotte Thålin et al.   ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY

S100A8/A9 in Inflammation

(2018) Siwen Wang et al.   Frontiers in Immunology

Calprotectin and calgranulin C serum levels in bacterial sepsis

(2018) Eva Bartáková et al.   DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE

Calprotectin Induces IL-6 and MCP-1 Production via Toll-Like Receptor 4 Signaling in Human Gingival Fibroblasts

(2017) Yasufumi Nishikawa et al.   JOURNAL OF CELLULAR PHYSIOLOGY

Pro-inflammatory S100 proteins are associated with glomerulonephritis and anti-dsDNA antibodies in systemic lupus erythematosus

(2016) H Tydén et al.   LUPUS

Serum calprotectin—a promising diagnostic marker for adult-onset Still’s disease

(2015) Qian Guo et al.   CLINICAL RHEUMATOLOGY

Inhibition of the autocrine IL-6–JAK2–STAT3–calprotectin axis as targeted therapy for HR−/HER2+breast cancers

(2015) Ruth Rodriguez-Barrueco et al.   GENES & DEVELOPMENT

Proinflammatory Proteins S100A8/S100A9 Activate NK Cells via Interaction with RAGE

(2015) Kenta Narumi et al.   JOURNAL OF IMMUNOLOGY

At the Bedside: Neutrophil extracellular traps (NETs) as targets for biomarkers and therapies in autoimmune diseases

(2015) April Barnado et al.   JOURNAL OF LEUKOCYTE BIOLOGY

Extracellular MRP8/14 is a regulator of β2 integrin-dependent neutrophil slow rolling and adhesion

(2015) Monika Pruenster et al.   Nature Communications

The accumulation of macrophages expressing myeloid-related protein 8 (MRP8) and MRP14 in the spleen of BALB/cA mice during infection with Plasmodium berghei

(2014) Haruka Mizobuchi et al.   EXPERIMENTAL PARASITOLOGY

Fecal calprotectin in diagnosis and clinical assessment of inflammatory bowel disease

(2014) Taina Sipponen et al.   SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY

Restoration of anti-Aspergillus defense by neutrophil extracellular traps in human chronic granulomatous disease after gene therapy is calprotectin-dependent

(2011) Matteo Bianchi et al.   JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY

Damage-Associated Molecular Pattern S100A9 Increases Bactericidal Activity of Human Neutrophils by Enhancing Phagocytosis

(2011) J.-C. Simard et al.   JOURNAL OF IMMUNOLOGY

Induction of neutrophil degranulation by S100A9 via a MAPK-dependent mechanism

(2010) Jean-Christophe Simard et al.   JOURNAL OF LEUKOCYTE BIOLOGY

The endogenous Toll-like receptor 4 agonist S100A8/S100A9 (calprotectin) as innate amplifier of infection, autoimmunity, and cancer

(2009) Jan M. Ehrchen et al.   JOURNAL OF LEUKOCYTE BIOLOGY

Neutrophil Extracellular Traps Contain Calprotectin, a Cytosolic Protein Complex Involved in Host Defense against Candida albicans

(2009) Constantin F. Urban et al.   PLoS Pathogens

Myeloid-related protein 8/14 and the risk of cardiovascular death or myocardial infarction after an acute coronary syndrome in the Pravastatin or Atorvastatin Evaluation and Infection Theraphy: Thrombolysis in Myocardial Infarction (PROVE IT-TIMI 22) trial

(2007) David A. Morrow et al.   AMERICAN HEART JOURNAL